{"id":176,"date":"2019-10-17T22:05:57","date_gmt":"2019-10-17T22:05:57","guid":{"rendered":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/chapter\/4-9-alpha-1-antagonists\/"},"modified":"2021-12-07T11:10:39","modified_gmt":"2021-12-07T11:10:39","slug":"4-9-alpha-1-antagonists","status":"publish","type":"chapter","link":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/chapter\/4-9-alpha-1-antagonists\/","title":{"raw":"4.9 Alpha-1 Antagonists","rendered":"4.9 Alpha-1 Antagonists"},"content":{"raw":"Tamsulosin is an Alpha-1 antagonist.\n\n<strong>Mechanism of Action:<\/strong>\u00a0 Tamsulosin selectively blocks alpha receptors in the prostate, leading to the relaxation of smooth muscles in the bladder, neck, and prostate, thus improving urine flow and reducing symptoms of benign prostatic hypertrophy (BPH).\n\n<strong>Indications:<\/strong> Tamsulosin is used to treat BPH.\n\n<strong>Nursing Considerations:<\/strong> Avoid using with other alpha-blockers. Tamsulosin is contraindicated with strong CYP3A4 inhibitors such as ketoconazole. Assess and monitor blood pressure, especially after first dose because tamsulosin may cause orthostatic hypotension.\n\n<strong>Patient Teaching &amp; Education<\/strong>: Advise patients to change positions slowly because the drug may cause orthostatic blood pressure changes.\u00a0 Additionally, the patient should take the medication at the same time each day.\u00a0 The patient should follow up with their healthcare provider to assess the effectiveness of the medication.<sup>[footnote]uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]<\/sup>\n\nNow let's take a closer look at the medication grid on tamsulosin in Table 4.9.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" target=\"_blank\" rel=\"noopener noreferrer\">Daily Med<\/a> by <a href=\"https:\/\/www.nlm.nih.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" target=\"_blank\" rel=\"noopener noreferrer\">public domain<\/a>.[\/footnote]<\/sup>\n\nTable 4.9 Tamsulosin Medication Grid\n<table class=\"grid\" border=\"0\">\n<tbody>\n<tr>\n<th style=\"width: 131.063px\" scope=\"col\">\n<h5><strong>Class\/Subclass<\/strong><\/h5>\n<\/th>\n<th style=\"width: 164.063px\" scope=\"col\">\n<h5><strong>Prototype\/Generic<\/strong><\/h5>\n<\/th>\n<th style=\"width: 389.063px\" scope=\"col\">\n<h5><strong>Administration Considerations<\/strong><\/h5>\n<\/th>\n<th style=\"width: 360.063px\" scope=\"col\">\n<h5><strong>Therapeutic Effects<\/strong><\/h5>\n<\/th>\n<th style=\"width: 256.063px\" scope=\"col\">\n<h5><strong>Side\/Adverse Effects<\/strong><\/h5>\n<\/th>\n<\/tr>\n<tr>\n<th style=\"width: 131.063px\" scope=\"row\">Alpha-1 antagonist<\/th>\n<td style=\"width: 164.063px\"><a class=\"rId72\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=ed9988bc-0759-4c36-bee1-11b68dc1c84c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>tamsulosin<\/strong><\/a><\/td>\n<td style=\"width: 389.063px\">Avoid using with other alpha- blockers\n\nAssess and monitor blood pressure, especially after first dose<\/td>\n<td style=\"width: 360.063px\">Relaxes smooth muscle in bladder\/prostate to improve urine flow<\/td>\n<td style=\"width: 256.063px\">Hypotension, especially after first dose. Advise patient to change positions slowly<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n&nbsp;","rendered":"<p>Tamsulosin is an Alpha-1 antagonist.<\/p>\n<p><strong>Mechanism of Action:<\/strong>\u00a0 Tamsulosin selectively blocks alpha receptors in the prostate, leading to the relaxation of smooth muscles in the bladder, neck, and prostate, thus improving urine flow and reducing symptoms of benign prostatic hypertrophy (BPH).<\/p>\n<p><strong>Indications:<\/strong> Tamsulosin is used to treat BPH.<\/p>\n<p><strong>Nursing Considerations:<\/strong> Avoid using with other alpha-blockers. Tamsulosin is contraindicated with strong CYP3A4 inhibitors such as ketoconazole. Assess and monitor blood pressure, especially after first dose because tamsulosin may cause orthostatic hypotension.<\/p>\n<p><strong>Patient Teaching &amp; Education<\/strong>: Advise patients to change positions slowly because the drug may cause orthostatic blood pressure changes.\u00a0 Additionally, the patient should take the medication at the same time each day.\u00a0 The patient should follow up with their healthcare provider to assess the effectiveness of the medication.<sup><a class=\"footnote\" title=\"uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral\" id=\"return-footnote-176-1\" href=\"#footnote-176-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a><\/sup><\/p>\n<p>Now let&#8217;s take a closer look at the medication grid on tamsulosin in Table 4.9.<sup><a class=\"footnote\" title=\"This work is a derivative of Daily Med by U.S. National Library of Medicine in the public domain.\" id=\"return-footnote-176-2\" href=\"#footnote-176-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><\/sup><\/p>\n<p>Table 4.9 Tamsulosin Medication Grid<\/p>\n<table class=\"grid\">\n<tbody>\n<tr>\n<th style=\"width: 131.063px\" scope=\"col\">\n<h5><strong>Class\/Subclass<\/strong><\/h5>\n<\/th>\n<th style=\"width: 164.063px\" scope=\"col\">\n<h5><strong>Prototype\/Generic<\/strong><\/h5>\n<\/th>\n<th style=\"width: 389.063px\" scope=\"col\">\n<h5><strong>Administration Considerations<\/strong><\/h5>\n<\/th>\n<th style=\"width: 360.063px\" scope=\"col\">\n<h5><strong>Therapeutic Effects<\/strong><\/h5>\n<\/th>\n<th style=\"width: 256.063px\" scope=\"col\">\n<h5><strong>Side\/Adverse Effects<\/strong><\/h5>\n<\/th>\n<\/tr>\n<tr>\n<th style=\"width: 131.063px\" scope=\"row\">Alpha-1 antagonist<\/th>\n<td style=\"width: 164.063px\"><a class=\"rId72\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=ed9988bc-0759-4c36-bee1-11b68dc1c84c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>tamsulosin<\/strong><\/a><\/td>\n<td style=\"width: 389.063px\">Avoid using with other alpha- blockers<\/p>\n<p>Assess and monitor blood pressure, especially after first dose<\/td>\n<td style=\"width: 360.063px\">Relaxes smooth muscle in bladder\/prostate to improve urine flow<\/td>\n<td style=\"width: 256.063px\">Hypotension, especially after first dose. Advise patient to change positions slowly<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-176-1\">uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a> <a href=\"#return-footnote-176-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-176-2\">This work is a derivative of <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" target=\"_blank\" rel=\"noopener noreferrer\">Daily Med<\/a> by <a href=\"https:\/\/www.nlm.nih.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" target=\"_blank\" rel=\"noopener noreferrer\">public domain<\/a>. <a href=\"#return-footnote-176-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><\/ol><\/div>","protected":false},"author":2,"menu_order":9,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":"cc-by"},"chapter-type":[49],"contributor":[],"license":[53],"class_list":["post-176","chapter","type-chapter","status-publish","hentry","chapter-type-numberless","license-cc-by"],"part":149,"_links":{"self":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/176","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/users\/2"}],"version-history":[{"count":1,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/176\/revisions"}],"predecessor-version":[{"id":177,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/176\/revisions\/177"}],"part":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/149"}],"metadata":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/176\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=176"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=176"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=176"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}